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Haemotropic haemoplasmas are Gram-negative epicel-
lular parasites of erythrocytes that have been re-classi-
fied to the genus Mycoplasma owing to results from 
sequencing of the 16S rRNA genes.1,2 Three different 
haemoplasma species have been identified in cats:3–5 (i) 
Mycoplasma haemofelis (Mhf), known previously as 
Haemobartonella felis large variant; (ii) Candidatus 
Mycoplasma haemominutum (CMhm), known previ-
ously as Haemobartonella felis; and (iii) Candidatus 
Mycoplasma turicensis (CMt), discovered in Switzerland 
in 2005. In 2007, a fourth haemoplasma called Candidatus 
Mycoplasma haematoparvum-like was identified in 
cats.6 In dogs, two different haemotropic mycoplasmas 
have been identified: Mycoplasma haemocanis (formerly 
Haemobartonella canis) and Candidatus Mycoplasma 
haematoparvum (CMhp).7 Overall, phylogenetic studies 
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Abstract
The diagnosis of feline haemoplasmosis has improved over the years, with several techniques enabling a clear and 
specific diagnosis, and where polymerase chain reaction (PCR) is considered as the ‘gold standard’. The aim of 
this study was to survey the prevalence of feline haemoplasmas in 320 cats from the north-central region of Portugal 
by the use of real-time PCR, as well as to evaluate any associations between infection, clinical presentation and 
risk factors. The overall prevalence of infection by feline haemoplasmas was 43.43% (139/320), where 41.56% 
(133/320) corresponded to Candidatus Mycoplasma haemominutum (CMhm), 12.81% (41/320) to Mycoplasma 
haemofelis (Mhf), 4.38% (14/320) to Candidatus Mycoplasma haematoparvum and 1.25% (4/320) to Candidatus 
Mycoplasma turicensis. Almost 13% (47/320) of the samples were co-infected, with the most common co-infection 
being CMhm and Mhf (23.74%). Infection was found statistically significant with feline immunodeficiency/feline 
leukaemia virus status (P = 0.034), but no significant association was found for breed, sex, fertility status (neutered/
spayed/entire), age, clinical status, living conditions (in/outdoor), anaemia status, or the presence/absence of ticks 
or fleas. Cats from north-central Portugal are infected with all the known feline haemoplasma species, with CMhm 
being the most common one. Prevalence of all feline haemoplasmas was higher than that reported previously 
in cats from other European countries, but similar to that described in Portugal for dogs. These data provide a 
better perspective regarding Mycoplasma species infection in Europe, and new information that helps us better 
understand feline haemoplasmosis.
Accepted: 1 February 2013
1 Department of Animal and Food Science, Center for Research 
in Agricultural Genomics (CRAG), Autonomous University of 
Barcelona (UAB), Barcelona, Spain
2 Department of Veterinary Sciences, University of Trás-os-Montes 
e Alto Douro, Vila Real, Portugal
3 Department of Veterinary Medicine, Vasco da Gama University 
School Coimbra, Coimbra, Portugal
4 Baixo Vouga Veterinary Hospital, Águeda, Portugal
5 Department of Animal Medicine and Surgery, Autonomous 
University of Barcelona (UAB), Barcelona, Spain
6 Molecular Genetics Veterinary Service (SVGM), Department of 
Animal and Food Science, Autonomous University of Barcelona 
(UAB), Barcelona, Spain
Corresponding author:
Verónica L Martínez-Díaz DVM MRes, Autonomous University of 
Barcelona (UAB) Campus, CRAG Building, Office 301, 08193 
Bellaterra, Barcelona, Spain 
Email: veronica.martinez@cragenomica.es
480985 JFM151010.1177/1098612X13480985Journal of Feline Medicine and SurgeryMartínez-Díaz et al
2013
Original Article
880 Journal of Feline Medicine and Surgery 15(10)
have shown that although Mhf and M haemocanis are dis-
tinct species, they are closely related, as well as to CMhm 
and CMhp.8
Feline haemoplasmosis can be diagnosed by cytology 
examination of stained blood smears, but cytological 
diagnosis has poor sensitivity and specificity owing to 
intrinsic limitations, such as stain precipitates, Howell–
Jolly bodies and artifacts caused by slow blood smear 
drying. Moreover, blood smears can’t differentiate 
between haemoplasma species, and, because of the cyclic 
nature of the parasitaemias, the absence of Mhf organ-
isms in blood films does not rule out the diagnosis of 
haemotrophic mycoplasmosis.2 Currently, polymerase 
chain reaction (PCR) techniques have been developed to 
diagnose Mycoplasma species infections, offering better 
reliability as they are more sensitive than cytology exam-
ination.9 The use of real-time PCR (qPCR) has been 
extended as it is more sensitive than conventional PCR 
and it allows quantification of the amount of haemo-
plasma DNA present in a cat’s blood, helping to deter-
mine the significance of the haemoplasma infection and 
to monitor the response to treatment. qPCR does not 
need post-PCR treatment therefore reducing the risk of 
sample contamination at the diagnostic laboratory. qPCR 
testing has been beneficial in testing clinically healthy 
cats being screened as blood donors or for entry into spe-
cific pathogen-free colonies.10
In Europe, prevalence studies carried out in Italy,11 
UK,12,13 Germany,14–16 Greece,17 Switzerland18,19 and 
Spain20 based on PCR results report an overall preva-
lence of Mycoplasma species ranging from 7.2% to 30%. 
CMhm is the most common type of Mycoplasma species 
ranging from 9.6% to 66.6%, followed by Mhf and CMt 
with prevalences of infection of 1.3–33.3% and 0.3–2.1%, 
respectively. CMt infection is associated with co-infec-
tion with either, and occasionally both, of the two other 
feline haemoplasma species, particularly with CMhm,8 
inducing moderate-to-severe anaemia.19 The nature of 
the cat’s sampled for these studies included samples 
from healthy cats to cats suspected of having haemoplas-
mosis. They also belonged to different geographical 
locations — a  variable that is believed to play an impor-
tant role in the rates of infection as warmer climates have 
higher rates of prevalence.18,20 To our knowledge, no pre-
vious studies on feline haemoplasmas have been carried 
out in Portugal. Therefore, the aims of this study were to 
survey the prevalence of feline mycoplasmas in 320 
Portuguese cats by the use of qPCR, as well as to evalu-
ate any associations between infection, clinical presenta-
tion and risk factors.
Materials and methods
Sample collection
Three hundred and twenty ethylenediamine tetra-acetic 
acid-anticoagulated blood samples were collected from 
both stray cats (rescued for animal shelters) and client-
owned cats with indoor/outdoor access in Portugal. 
These samples were collected by veterinarians at the 
time of clinical presentation and frozen at –20°C until 
DNA extraction. Data obtained at the time of presenta-
tion included age, breed, gender, living condition, geo-
graphical region and clinical status (healthy vs unhealthy 
was determined based on the reason for presentation 
and physical examination). Data collected in a retrospec-
tive manner if available were feline leukaemia virus 
(FeLV)/feline immunodeficiency virus (FIV) status 
(determined by SNAP FIV/FeLV Combo Test) and the 
presence of ticks and/or fleas. Haematology was per-
formed when requested by the attending veterinarian. 
Packed red cell volume (PCV) value was considered nor-
mal when values ranged from 25% to 45%, and anaemia 
was defined as PCV <25% according to the reference 
interval of our laboratory.
DNA isolation and qPCR amplification
DNA was obtained from 0.5 ml of peripheral whole 
blood as described previously.21 Amplification of 
Mycoplasma species and the different species in positive 
samples (Mhf, CMhm, CMt and CMhp) were carried out 
in a final volume of 20 µl using FastStart Universal 
SYBR Green Master (Roche), 0.3 µM of each primer 
(with the exception of reverse primer of CMt at 0.5 µM) 
and 4 µl of diluted DNA. The thermal cycling profile 
was 50°C for 2 mins and 95°C for 10 mins followed by 
40 cycles at 95°C for 15 s and 60°C for 1 min. The PCR 
primers were designed with Primer Express 2.0 
(Applied Biosystems) based on conserved regions of 
16S ribosomal RNA gene for Mycoplasma species. The 
specificity of each PCR primer pair included (i) in silico 
analysis; (ii) sequencing the positive controls; and (iii) 
performing a cross-amplification study in which ampli-
fication with specific primers was performed over all 
the positives of other pathogens available in our labora-
tory (pathogens that could be in co-infection in cats, 
mostly vector borne diseases). Expected results were 
amplification of the specific Mycoplasma-positive sam-
ple and no amplification of any of the other pathogens 
tested. Validation of the PCR included the analysis of 
clinical samples suspected of being infected by the 
pathogen and the sequencing of any spurious or unspe-
cific amplification that could occur.
Internal controls were added to all the samples ana-
lysed and all the PCRs performed. Negative controls 
include negative extraction control for the DNA extrac-
tion and a negative template control for the PCR. Positive 
qPCR controls were obtained from clinical samples that 
had been amplified previously and sequenced to con-
firm the pathogen. The sequences of the primers used 
and assay temperatures (dissociation curve analysis) are 
shown in Table 1.
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The eukaryotic 18S RNA Pre-Developed TaqMan 
Assay Reagents (Applied Byosystems) was used as 
internal reference for cat genomic DNA amplification to 
ensure proper qPCR amplification of each sample and 
that negative results corresponded to true negative sam-
ples rather than to a problem with DNA loading, sample 
degradation or PCR inhibition. The use of an endoge-
nous control (18S RNA) that amplified between cycle 
threshold 19–21 in all samples corroborate that similar 
amounts of genomic DNA were used in all PCRs.
Statistical analysis
Difference between groups was tested for significance by 
χ2 analysis (cell frequencies >5) or Fisher’s exact test (cell 
frequencies ≤5). A P-value <0.05 was considered statisti-
cally significant. For the observed prevalence, the 95% 
confidence interval (CI) was calculated. Potential risk 
factors were evaluated by calculating the odds ratio with 
a 95% CI, and P-value <0.05 was considered statistically 
significant. All available data were analysed using 
MedCalc Software.22
Results
A total of 320 cats (175 males and 136 females), ranging 
in age from 0.5 to 20 years (median 4.23 years) from the 
north and north-central regions of Portugal were 
included in the study. Most samples came from the dis-
trict of Aveiro (36.87%; 118/320). The other samples 
came from Oporto 14.37% (46/320), Coimbra 13.12% 
(42/320) and 35.62% from Braga, Bragança, Leiria, Viana 
do Castelo, Vila Real and Viseu (114/320).
Pedigree cats represented only 14.6% of the cohort, 
which included 26 Persian, 11 Siamese, three Norwegian 
Forest, two Sphynx, one Birman and one Chartreaux. 
The remaining 85.4% were domestic shorthair cats. 
Females represented 43.7% (136/311) of the population, 
whereas males represented 56.2% (175/311); 40.4% 
(55/136) of the females and 46.8% of the males were 
PCR-positive. Over half the population of cats had out-
door access [61.1% (189/320)] and 60.5% (184/320) were 
classified as sick when presented to the veterinary clinic, 
44.5% (82/184) of whom were PCR-positive for feline 
haemoplasmas. Regarding antibiotic treatment, infor-
mation was available for only 21 cats (6.25%). Antibiotics 
used in these 21 cats were amoxicillin, esperamicin, 
enrofloxacin, doxycycline and cefalexin, but only eight 
cats were receiving enrofloxacin or doxycycline as treat-
ment for mycoplasmosis.
Table 2 summarises all the data for breed, sex, fertility 
status (neutered/spayed/entire), indoor/outdoor sta-
tus, age, clinical status, PCV, presence/absence of ticks 
or fleas and FIV/FeLV status.
The overall sample prevalence for Mycoplasma species 
infection was 43.44% (139/320): 41.56% (133/320) were 
infected with CMhm; 12.81% (41/320) with Mhf; 4.38% 
(14/320) with CMhp and 1.25% (4/320) with CMt. Forty-
two samples were co-infected with two types of 
Mycoplasma species, with the most common co-infection 
being CMhm + Mhf; four samples were co-infected with 
three types of Mycoplasma species and one sample pre-
sented positive results for all the Mycoplasma species 
tested. Overall co-infection sample prevalence was 
14.68% (47/320). The results are summarised in Table 3.
Table 1 Primer sequences for Mycoplasma real-time PCR assays and species-specific melting temperatures












GGCGGTGTGTACAAGACCTGG 0.3  
Mycoplasma 
haemofelis — R


















TGAATRTGTTTTYAAATGCYCCTT 0.5 76.3 ± 0.3
*PCR performed with HT7900 (AB Life Technologies) and SYBRGreen (Roche)
†The same forward primer was used for all the Mycoplasma species PCR assays
F = forward; R = reverse
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The highest sample prevalence of infected cats was 
found in Viseu (73.33%, P = 0.02, odds ratio: 3.65, 95% 
CI = 1.13–11.73) (Table 4). FIV/FeLV status was statisti-
cally significant (P = 0.03, odds ratio: 2.6, 95% CI = 1.07–
6.62) when comparing clinically sick cats (15/82) and 
healthy cats (1/50) with positive Mycoplasma species 
qPCR (Table 2). No significant P-value was found for 
breed, sex, fertility status (neutered/spay/entire), age, 
clinical status, presence/absence of ticks or fleas, living 
conditions or anaemia status in the overall population.
The majority of the samples that amplified Mhf were 
co-infected with CMhm alone (33/41), although multiple 
co-infections with additional species were also detected 
(3/41 CMhm + Mhf + CMhp and 1/41 Mhf + CMhm + 
CMhp + CMt). There was a statistical significance when 
comparing breeds (pedigree vs non-pedigree) with an 
odds ratio of 2.25 (95% CI 1.01–5.01) and a P value of 0.04 
for cats infected with Mhf.
Only 14 samples were positive for CMhp. All the sam-
ples that amplified for this type of haemoplasma were 
co-infected (14/320): nine with CMhm, one with 
CMt+CMhm and three with CMhm+Mhf. Only four sam-
ples were positive for CMt. Two of these samples were 
co-infected, and 3/4 samples belonged to sick cats with 
outdoor access.
Discussion
This study documents the occurrence of Mhf, CMhm, 
CMhp and CMt in naturally-infected cats from the north-
central area of Portugal. To our knowledge, no previous 
studies have reported on the prevalence of feline haemo-
plasmas in Portugal. Previous studies have only been 
Table 2 Sample characteristics. Data from animals that had no available information were not analysed
Total number % Total % Positive Positive Odds ratio 95% CI P
Breed  
Pedigree 44 14,06 43.18 19 0.94 0.49–1.79 0.86
Non-pedigree 269 85.94 44.61 120  
Gender  
♀ 136 43.73 40.44 55  
♂ 175 56.27 46.86 82 0.77 0.48–1.21 0.25
Spayed ♀ 63 20.26 38.10 24  
Entire ♀ 73 23.47 42.47 31 0.83 0.41–1.65 0.60
Neutered ♂ 93 29.90 43.01 40  
Entire ♂ 82 26.37 51.22 42 0.71 0.39–1.30 0.27
Living condition  
Indoor 120 38.83 40.00 48  
Outdoor 189 61.17 47.09 89 0.74 0.47–1.19 0.22
FeLV/FIV status  
Positive 26 24.53 61.54 16  
Negative 80 75.47 37.50 30 2.6 1.07–6.6 0.03
Age (years)  
<1 87 28.52 42.53 37 0.88 0.53–1.46 0.64
>1–3 84 27.54 41.67 35 0.84 0.51–1.4 0.52
4–9 97 31.80 47.42 46 1.18 0.72–1.91 0.49
>10 37 12.13 48.65 18 1.20 0.60–2.39 0.59
Clinical status  
Healthy 120 39.47 41.67 50  
Unhealthy 184 60.53 44.57 82 0.88 0.55–1.41 0.61
PCV  
Anaemia 35 59.32 57.14 22  
Normal 24 40.68 41.67 10 2.36 0.81–6.85 0.11
Ticks/fleas  
Yes 51 28.81 49.02 25  
No 126 71.19 44.44 56 1.20 0.62–2.30 0.58
Geographical region  
Interior 94 29.38 45.74 43  
Coastal 219 68.44 43.84 96 1.08 0.66–1.75 0.75
CI = confidence interval; FeLV = feline leukaemia virus; FIV = feline immunodeficiency virus; PCV = packed cell volume
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conducted on canine samples, reporting a prevalence for 
haemoplasma infection of 40%23 which is similar to  that 
found in our study for the cat population. The preva-
lence rates observed in Portugal are higher than those of 
other European countries, such as Spain20,24 Greece,17 
Italy,11 the UK,12,13,19 Switzerland18 or Germany14–16 which 
range from 7.2% to 30%. Differences in prevalence 
among countries could be explained by geographical 
variations, such as climate, vector distribution and the 
cat population per se. Moreover, direct comparisons of 
prevalence results are of limited value because of sample 
characteristics, inclusion criteria, diagnostic techniques, 
different statistical methods or a combination of them 
all, resulting in discrepancies between studies. Most of 
the cats in our study were cats with outdoor access, 
which means that they have a higher chance of 
Mycoplasma species infection as a result of their living 
style (more exposure to vectors like ticks and fleas which 
could transmit Mycoplasma species, higher chance of 
FIV/FeLV transmission, etc).
In our Portuguese samples CMhm was the most prev-
alent haemoplasma found, as has been described previ-
ously.25,26 In fact, Reynolds and Lappin27 suggest that 
CMhm may be a primary pathogen in some naturally-
infected cats. Some studies indicate that CMhm infection 
is less pathogenic when compared with other feline 
mycoplasmas,4,18 and some reports, such as one from 
Spain,20 as well as our study, have failed to demonstrate 
an association between anaemia and Mycoplasma species 
infection. A limitation to our study was that a complete 
blood count was not performed for all 320 cats.
Mhf has been classified as the most pathogenic 
Mycoplasma species in cats.9 Cats during the acute phase 
of infection with Mhf develop anaemia as a result of 
extravascular erythrophagocytosis by macrophages in 
the liver, spleen, lungs and bone marrow. In chronic 
phases of infection anaemia may not be present.2 
Conversely, various studies of naturally-infected cats, 
including ours, have failed to demonstrate an associa-
tion between anaemia and Mhf infection.12,20,25 Different 
Table 3 Haemoplasma detection by real-time PCR
Pathogen Number of infected cats Prevalence 95% CI
Mycoplasma species 139/320 0.434 0.365–0.512
Mycoplasma haemofelis (Mhf) 4/320 0.028 0.007–0.07
Candidatus Mycoplasma Haemominutum (CMhm) 86/320 0.618 0.494–0.764
Candidatus Mycoplasma turicensis (CMt) 2/320 0.014 0.001–0.051
Candidatus Mycoplasma Haematoparvum (CMhp) 0/320 0 0–0.026
Dual CMhm + CMhp 9/320 0.064 0.029–0.122
Dual CMhm + CMhp 33/320 0.024 0.163–0.333
Triple CMhm + Mhf + CMhp 3/320 0.022 0.004-–0.063
Triple CMt + CMhp + CMhm 1/320 0.007 0.001–0.04
Quadruple Mhf + CMhm + CMhp + CMt 1/320 0.007 1E–40.0001–0.04
Table 4 Prevalence of Mycoplasma infection by geographical region
District  
n = 320












Aveiro 118 51 67 0.43 0.32–0.56 0.37 0.27–0.48
Braga 7 2 5 0.28 0.03–1.03 0.01 1 E–3–0.05
Braganza 8 4 4 0.5 0.13–1.28 0.03 0.00–0.07
Coimbra 42 23 19 0.54 0.34–0.82 0.17 0.10–0.21
Leiria 2 1 1 0.5 0.01–2.78 0.01 0.00–0.04
Madeira 1 0 1 0 0.00–3.68 0 0.00–0.02
Oporto 46 16 30 0.31 0.19–0.56 0.11 0.06–0.18
Viana do 
Castelo
3 3 0 1 0.20–2.92 0.02 4 E–3–0.06
Vilareal 71 28 43 0.39 0.26–0.57 0.20 0.13–0.29
Viseu 15 11 4 0.73 0.36–1.31 0.08 0.03–0.14
ND 7 2 5  
CI = confidence interval; ND = no data
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results might occur owing to different cat populations, 
the presence of different isolates of Mhf involved co-
infections with other Mycoplasma species and the 
underlying health status of the cats. Most of the cats 
infected with Mhf in our study were co-infected with 
other types of Mycoplasma species, making it difficult to 
explain any association with the risks factors included. 
In our study, Mhf + CMhm co-infection was the most 
common co-infection, with a sample prevalence of 
23.7% (95% CI 16.3–33.3%), although it was considered 
rare in previous articles with prevalences ranging from 
0.2% to 4.9%.11,12,15,16,18,28,29
Regarding CMhp infection, we have detected, by 
means of a qPCR assay, molecular evidence of infection 
in 4.37% (14/320) of cats. All of the qPCR CMhp-positive 
cats were co-infected with other types of Mycoplasma 
species, with the most common co-infection being CMhp 
+ CMhm (9/14) followed by triple co-infections with 
CMhp + CMhm + Mhf (3/14). These results are higher 
than the prevalence rate reported by Sykes et al,6 who 
reported a 0.7% prevalence in anaemic and non-anaemic 
cats from the USA. Other studies performed in the USA30 
or Italy11 have failed to find any evidence of CMhp infec-
tion in cats. Further prevalence studies should be per-
formed in different countries to understand the 
pathogenicity of this species of Mycoplasma.
In the case of CMt infection, 2.8% (4/139) of cats were 
positive for CMt, a sample prevalence rate similar to that 
reported in UK19 and greater than those observed in 
other European studies of 1.1%,16 0.8%,13 0.7%,15 0.5%,20 
0.4%5 and 0.3%.11 It has been described that cats infected 
with CMt have significantly lower blood copy numbers 
than cats infected with Mhf or CMhm as these cats 
become qPCR-negative as early as 45 days after infec-
tion, while cats infected with Mhf or CMhm remain 
qPCR-positive even after 85 days after infection.9 In fact, 
eight cats in our study were receiving or had received 
antibiotic (enrofloxacin, doxycycline) treatment before 
qPCR analysis, and five of these cats remained qPCR-
positive for CMhm, indicating that long-term carrier sta-
tus is common in comparison to infection with other 
Mycoplasma species, as reviewed by Tasker.9
There was no significant difference in overall haemo-
plasma sample prevalence between healthy and 
unhealthy cats, which could be explained by chronic 
infection detection rather than an acute infection, and 
the presence/absence of other diseases which may not 
have been reported. It has been reported that 10% of 
healthy cats can be infected with feline haemoplasma at 
any point in their lives.9 These data should be kept in 
mind when interpreting qPCR results, as a positive 
result does not always correlate with clinical disease. 
A diagnosis of mycoplasmosis should be based on the 
patient’s physical findings, biochemistry and haemato-
logical tests, as well as qPCR results.31
Results regarding the geographical region have to be 
interpreted with caution. Although microclimate varia-
tions within the same climate area could influence the 
epidemiology of haemoplasma infections,11 it is not safe 
to assume that one district is more at risk of having a 
higher prevalence of a specific type of haemoplasma 
because not all districts had the same sample size (sam-
ple size was relatively low in most of the districts). 
Furthermore, indoor or outdoor habitat may function as 
a cofactor in different geographic areas.
Contradictory results have been reported on whether 
concomitant FIV and FeLV infections could predispose 
to haemoplasma infections, favouring the chronic carrier 
state or worsen the clinical course.6,11,13,32,33 In our study, 
being FIV- or FeLV-positive was a risk factor for haemo-
plasma infection, which is in agreement with previous 
studies,11 but results should be interpreted carefully as 
FIV/FeLV status was only determined in 33.12% of the 
cats in this study.
Conclusions
Cats from north-central Portugal are infected with all the 
known feline haemoplasma species, with CMhm being 
the most common one. The sample prevalence of all 
feline haemoplasmas was higher than that reported pre-
viously in cats from other European countries, but simi-
lar to that described in Portugal for dogs. These data 
provide a better perspective regarding Mycoplasma spe-
cies infection in Europe and new information that helps 
us better understand feline haemoplasmosis.
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